Добірка наукової літератури з теми "Daunorubicin"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Daunorubicin".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Daunorubicin"
Drevin, Guillaume, Marie Briet, Caroline Bazzoli, Emmanuel Gyan, Aline Schmidt, Hervé Dombret, Corentin Orvain, et al. "Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial." Pharmaceutics 14, no. 4 (April 5, 2022): 792. http://dx.doi.org/10.3390/pharmaceutics14040792.
Повний текст джерелаZucchetti, Massimo, Amerigo Boiardi, Antonio Silvani, Idria Parisi, Stefano Piccolrovazzi, and Maurizio D'Incalci. "Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin." Cancer Chemotherapy and Pharmacology 44, no. 2 (June 17, 1999): 173–76. http://dx.doi.org/10.1007/s002800050964.
Повний текст джерела&NA;. "Daunorubicin see Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 354 (June 1991): 8. http://dx.doi.org/10.2165/00128415-199103540-00027.
Повний текст джерелаCusack, B. J., Stephan P. Young, Robert E. Vestal, and Richard D. Olson. "Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat." Cancer Chemotherapy and Pharmacology 39, no. 6 (February 28, 1997): 505–12. http://dx.doi.org/10.1007/s002800050606.
Повний текст джерелаChoi, Min-Koo, Im-Sook Song, Dae-Duk Kim, Suk-Jae Chung, and Chang-Koo Shim. "Altered Pharmacokinetics of Daunorubicin in Rats with CCl4-Induced Hepatic Injury." Journal of Pharmacy & Pharmaceutical Sciences 10, no. 4 (September 16, 2007): 443. http://dx.doi.org/10.18433/j3mw28.
Повний текст джерелаAlbrecht, K. W., S. Leenstra, P. J. M. Bakker, J. H. Beijnen, D. Troost, P. Kaaijk, and D. A. Bosch. "High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin." Clinical Neurology and Neurosurgery 99 (July 1997): S231. http://dx.doi.org/10.1016/s0303-8467(97)82346-3.
Повний текст джерела&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1184 (January 2008): 15. http://dx.doi.org/10.2165/00128415-200811840-00044.
Повний текст джерела&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 562 (August 1995): 6. http://dx.doi.org/10.2165/00128415-199505620-00017.
Повний текст джерела&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 392 (March 1992): 5. http://dx.doi.org/10.2165/00128415-199203920-00013.
Повний текст джерела&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 398 (April 1992): 6. http://dx.doi.org/10.2165/00128415-199203980-00014.
Повний текст джерелаДисертації з теми "Daunorubicin"
Golightly, L. "Trypanosmoma brucei : Studies on the uptake and effects of daunorubicin and daunorubicin carrier preparations." Thesis, University of Sunderland, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.375648.
Повний текст джерелаHardman, Mark Alan. "Design of potential antiprotozoal daunorubicin derivatives." Thesis, De Montfort University, 1985. http://hdl.handle.net/2086/10737.
Повний текст джерелаMohammed, Lina Yousif. "Studies on daunorubicin and actinorhodin type II polyketide synthases." Thesis, University of Bristol, 2018. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.761209.
Повний текст джерелаWattana-Amorn, Pakorn. "Studies on the actinorhodin and daunorubicin type II polyketide synthases." Thesis, University of Bristol, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.441375.
Повний текст джерелаBartels, Anna-Maria. "Durchflusszytometrische Untersuchungen zur zellulären Pharmakokinetik von freien und liposomal verkapseltem Daunorubicin." [S.l.] : [s.n.], 2002. http://deposit.ddb.de/cgi-bin/dokserv?idn=965428001.
Повний текст джерелаMaharaj, Vanitha. "A vibrational circular dichroism study of deoxyoctanucleotides and their daunorubicin complexes." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/nq20751.pdf.
Повний текст джерелаBartels, Anna-Maria. "Durchflußzytometrische Untersuchungen zur zellulären Pharmakokinetik von freien und liposomal verkapseltem Daunorubicin." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2002. http://dx.doi.org/10.18452/14780.
Повний текст джерелаWe studied the cellular pharmacokinetics, including uptake, intracellular distribution and efflux, and the induction of apoptosis as a parameter of pharmacodynamics of the two anthracyclines, free and liposomal encapsulated daunorubicin. We used a flowcytometer and a confocal lasermicroscope to measure the intracellular fluorescence in CEM-cells, corresponding to the intracellular concentration of the drugs. Free daunorubicin invaded initially the cells much quicker than liposomal encapsulated daunorubicin and attained earlier the maximum concentration. After the examined time daunoxome achieved the same maximum concentration as daunorubicin. The invasion of liposomal encapsulated daunorubicin followed a sigmoid course, while free daunorubicin followed a saturation kinetic. It was shown that the uptake of both anthracyclines was time- and concentration-dependent. The examinations about the intracellular distribution showed, that both drugs accumulated in the nucleus after three hours of incubation. Daunorubicin attained quickly the maximum fluorescence there, while daunoxome increased slowly for the next six hours. The results of the apoptosis induction correlated to the results of the uptake experiments. Free daunorubicin induced initially quicker apoptosis than liposomal encapsulated daunorubicin. At the end of the measured time all the apoptosis rates of both drugs appeared to be equal. It was determined that the induction of apoptosis also is time- and concentration-dependent. The efflux of daunoxome was monophasic in contrast to a biphasic decline of daunorubicin. These results indicate that free daunorubicin has improved initial cellular pharmacokinetics and therefore enhanced cytotoxicity compared with liposomal encapsulated daunorubicin. But over the examined period both got equal cytotoxicity. Therefore daunoxome is on the cellular basis at least as effective as daunorubicin.
Battisti, Robert F. "Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance." Connect to resource, 2007. http://hdl.handle.net/1811/25067.
Повний текст джерелаTitle from first page of PDF file. Document formatted into pages: contains 48 p.; also includes graphics. Includes bibliographical references (p. 46-48). Available online via Ohio State University's Knowledge Bank.
Knaust, Eva. "Experimental studies on multidrug resistance in human leukaemia : role of cellular heterogeneity for daunorubicin kinetics /." Linköping : Dept. of Medicine and Care, Univ, 2005. http://www.bibl.liu.se/liupubl/disp/disp2005/med901s.pdf.
Повний текст джерелаMasquelier, Michèle. "Leukemia chemotherapy : experimental studies on pharmacological optimisation /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7140-046-X/.
Повний текст джерелаКниги з теми "Daunorubicin"
Hardman, Mark Alan. Design of potential antiprotozoal daunorubicin derivatives. Leicester: Leicester Polytechnic, 1985.
Знайти повний текст джерелаЧастини книг з теми "Daunorubicin"
Mader, Ines, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin." In Paravasation von Zytostatika, 118–22. Vienna: Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-3799-4_19.
Повний текст джерелаMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Daunorubicin." In Extravasation of Cytotoxic Agents, 175–82. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_26.
Повний текст джерелаMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin." In Extravasation of Cytotoxic Agents, 107–11. Vienna: Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_19.
Повний текст джерелаMader, Ines, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin liposomal." In Paravasation von Zytostatika, 123–26. Vienna: Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-3799-4_20.
Повний текст джерелаMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Daunorubicin liposomal." In Extravasation of Cytotoxic Agents, 183–86. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_27.
Повний текст джерелаMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Daunorubicin liposomal." In Extravasation of Cytotoxic Agents, 112–15. Vienna: Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_20.
Повний текст джерелаChaires, Jonathan B. "Molecular Recognition of DNA by Daunorubicin." In ACS Symposium Series, 156–67. Washington, DC: American Chemical Society, 1994. http://dx.doi.org/10.1021/bk-1995-0574.ch010.
Повний текст джерелаShrestha, Biplav, Anaya Raj Pokhrel, Sumangala Darsandhari, Prakash Parajuli, Jae Kyung Sohng, and Ramesh Prasad Pandey. "Engineering Streptomyces peucetius for Doxorubicin and Daunorubicin Biosynthesis." In Environmental Chemistry for a Sustainable World, 191–209. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-01881-8_7.
Повний текст джерелаKnaust, E., A. Gruber, A. Porwit-MacDonald, and C. Peterson. "Functional Studies of Daunorubicin Transport in Human Leukemic Cells." In Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, 515–20. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-71960-8_68.
Повний текст джерелаAtaullakhanov, Fazoil I., Elena V. Kulikova, and Victor M. Vitvitsky. "Binding of Daunorubicin and Doxorubicin to Erythrocytes Treated with Glutaraldehyde." In Erythrocytes as Drug Carriers in Medicine, 143–48. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-0044-9_19.
Повний текст джерелаТези доповідей конференцій з теми "Daunorubicin"
Sheng, Xia, Jean-Hugues Parmentier, Jonathan Tucci, Hua Pei, Omar Cortez-Toledo, Christina Dieli-Conwright, Matthew Oberley, et al. "Abstract 2960: Adipocytes sequester and metabolize daunorubicin." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-2960.
Повний текст джерелаRios-Doria, Jonathan, Tara L. Costich, Adam Carie, and Kevin Sill. "Abstract 4453: Development of a crosslinked, daunorubicin-loaded micelle with superior pharmacokinetics compared to free daunorubicin and with tunable stability." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4453.
Повний текст джерелаOsdal, Tereza, Lars P. Jordheim, Mihaela Popa, Lene M. Vikebø, Andre Sulen, Siv Lise Bedringaas, Marit Liland Sandvold, et al. "Abstract 3274: Combination of elacytarabine and daunorubicin is significantly more effective than combination of cytarabine and daunorubicin in primary patient xenografts of AML." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-3274.
Повний текст джерелаSheng, Xia, Jonathan Tucci, James Behan, and Steven D. Mittelman. "Abstract 172: Adipocytes decrease daunorubicin concentration in acute lymphoblastic leukemia cells." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-172.
Повний текст джерелаParmentier, Jean-Hugues, Christina M. Dieli-Conwright, and Steven D. Mittelman. "Abstract 3185: Adipocyte-derived hydrogen peroxide promotes chemoresistance to daunorubicin in leukemia cells." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3185.
Повний текст джерелаSheng, Xia, Jonathan Tucci, and Steven D. Mittelman. "Abstract 1247: Reduction of oxidative stress promotes daunorubicin resistance in acute lymphoblastic leukemia cells." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1247.
Повний текст джерелаCostich, Tara Lee, Rick Crouse, Adam Carie, Taylor Buley, Tyler Ellis, Lauren Repp, J. Edward Semple, Tomas Vojkovsky, Suzanne Bakewell, and Kevin Sill. "Abstract 1317: IT-143: A nanoparticle delivery platform that encapsulates daunorubicin and widens therapeutic window." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1317.
Повний текст джерелаContente, Thais C., Iara F. Kretzer, Durvanei A. Maria, Tathiana Capeto, Ricardo Fock, and Raul C. Maranhao. "Abstract 2656: Association of daunorubicin to a lipidic nanoemulsion (NEM-ODNR) - in vivo tumor growth inhibition." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2656.
Повний текст джерелаLin, Tara L., John M. Perry, Xi He, Gregory Reed, Na Zhang, Scott Weir, Joseph McGuirk, and Linheng Li. "Abstract CT103: Low-dose daunorubicin to target leukemia stem cells in newly diagnosed and relapsed/refractory AML." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-ct103.
Повний текст джерелаJelinkova, Ludmila, and Yuichiro Suzuki. "Effects Of Daunorubicin On Pulmonary Artery Smooth Muscle Cells In Rat Model Of Hypoxia-Induced Pulmonary Hypertension." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1181.
Повний текст джерела